118 related articles for article (PubMed ID: 1097596)
1. Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
Singh MM; Kay SR
J Nerv Ment Dis; 1975 Apr; 160(4):258-66. PubMed ID: 1097596
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
Singh MM; Kay SR
Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
Singh MM; Kay SR
Psychopharmacologia; 1975 Aug; 43(2):115-21. PubMed ID: 1103206
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping.
Singh MM; Kay SR; Opler LA
Psychol Med; 1987 Feb; 17(1):39-48. PubMed ID: 3575576
[TBL] [Abstract][Full Text] [Related]
5. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
Singh MM; Smith JM
J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
[No Abstract] [Full Text] [Related]
6. Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model.
Singh MM; Kay SR
Neuropsychobiology; 1979; 5(2):74-86. PubMed ID: 34804
[TBL] [Abstract][Full Text] [Related]
7. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
[TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
Swett C; Cole JO; Shapiro S; Slone D
Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
[TBL] [Abstract][Full Text] [Related]
9. Benztropine prophylaxis of dystonic reactions.
Stern TA; Anderson WH
Psychopharmacology (Berl); 1979 Mar; 61(3):261-2. PubMed ID: 36644
[TBL] [Abstract][Full Text] [Related]
10. Sleeplessness in acute and chronic schizophrenia--response to haloperidol and anti-parkinsonism agents.
Singh MM; Smith JM
Psychopharmacologia; 1973 Feb; 29(1):21-32. PubMed ID: 4571938
[No Abstract] [Full Text] [Related]
11. Medication may be required for the development of automatic information processing in schizophrenia.
Serper MR; Bergman RL; Harvey PD
Psychiatry Res; 1990 Jun; 32(3):281-8. PubMed ID: 2388967
[TBL] [Abstract][Full Text] [Related]
12. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
[TBL] [Abstract][Full Text] [Related]
13. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics.
Winslow RS; Stillner V; Coons DJ; Robison MW
Am J Psychiatry; 1986 Jun; 143(6):706-10. PubMed ID: 2872822
[TBL] [Abstract][Full Text] [Related]
14. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
Baker LA; Cheng LY; Amara IB
Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
[TBL] [Abstract][Full Text] [Related]
15. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
McEvoy JP; McCue M; Freter S
Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.
Kramer MS; Vogel WH; DiJohnson C; Dewey DA; Sheves P; Cavicchia S; Little P; Schmidt R; Kimes I
Arch Gen Psychiatry; 1989 Oct; 46(10):922-8. PubMed ID: 2679483
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
Marshall G; Kerr S; Vowels M; O'Gorman-Hughes D; White L
J Pediatr; 1989 Jul; 115(1):156-60. PubMed ID: 2661789
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
[TBL] [Abstract][Full Text] [Related]
19. Effects of phenothiazines and social skills training in a withdrawn schizophrenic.
Hersen M; Turner SM; Edelstein BA; Pinkston SG
J Clin Psychol; 1975 Oct; 31(4):588-94. PubMed ID: 1194410
[TBL] [Abstract][Full Text] [Related]
20. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
Singh MM
Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
